Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FWL92
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,650
Award facts
- Contract value 100% obligated
- $42,650.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,650.19 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on July 17, 2025, with an ultimate completion date of July 18, 2025. This non-set-aside contract represents a single delivery order fulfillment for a specialty pharmaceutical product used in the treatment of atopic dermatitis, eczema, and other inflammatory conditions. The award was made to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in competitively awarded pharmaceutical procurement across multiple therapeutic domains, positioning the company as a critical vendor within the Defense Logistics Agency's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FWL92?
SPE2DB25FWL92 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 17, 2025.
How much is contract SPE2DB25FWL92 worth?
The government has obligated $42,650 on SPE2DB25FWL92.
Is contract SPE2DB25FWL92 an order under another contract?
Yes. SPE2DB25FWL92 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWL92 competed?
The extent of competition for SPE2DB25FWL92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award